Licensable university IP
Immunoproteasome inhibitor analogs
Immunoproteasome inhibitor analogs is marketed for licensing by University of California. It is documented in US patent US 10,584,105. The current assignee of record is Michigan State University MSU. Google Patents reports its legal status as “Active” (an automated indicator, not a legal determination). Its expected expiration is 2037-03-10. Note: the patent's assignee of record is Michigan State University MSU, not University of California; confirm that University of California can license it before relying on this listing.
The patent's current assignee of record is Michigan State University MSU, which differs from the marketing institution (University of California). Confirm licensing rights with the assignee of record before relying on this listing.
Patent picture
| Field | Value | Reliability | Source |
|---|---|---|---|
| US patent | US 10,584,105 | High | Google Patents |
| Patent title | Immunoproteasome inhibitor analogs | High | Google Patents |
| Current assignee | Michigan State University MSU | Good | Google Patents |
| Original assignee | Michigan State University MSU | Good | Google Patents |
| Legal status | Active | Moderate | Google Patents |
| Filing date | 2017-03-10 | High | Google Patents |
| Priority date | 2016-03-11 | High | Google Patents |
| Publication date | 2020-03-10 | High | Google Patents |
| Expected expiration | 2037-03-10 | Moderate | Google Patents |
- High 90% and up
- Good 80 to 89%
- Moderate 70 to 79%
Legal status is Google Patents' automated indicator, not a legal determination.
Joined to US 10,584,105 by its printed patent number (a deterministic match), then enriched from public Google Patents data. Fields are shown only where resolved against a public source; unresolved fields are omitted, never guessed.
Original listing
This technology is marketed for licensing by University of California. View the original listing.